Risk of tuberculosis in a large sample of patients with coeliac disease - A nationwide cohort study

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 6, 2011, Pages 689-696

  Ludvigsson, J F ^a,b   Sanders, D S ^c   Maeurer, M ^b   Jonsson, J ^d   Grunewald, J ^b   Wahlstrom J ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM BIOPSY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFANT; INFECTION RISK; INTESTINE VILLUS ATROPHY; JEJUNUM BIOPSY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; SCHOOL CHILD; SWEDEN; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DUODENUM; EPIDEMIOLOGIC METHODS; HUMANS; INFANT; INFANT, NEWBORN; JEJUNUM; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; SEX DISTRIBUTION; SWEDEN; TUBERCULOSIS; YOUNG ADULT;

EID: 79951682960     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04572.x     Document Type: Article

References (35)

1. Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005; 4 (Suppl. 1): S57-67. (Pubitemid 40460823)
2. Ludvigsson JF, Ludvigsson J, Ekbom A, Montgomery SM,. Celiac Disease and Risk of Subsequent Type 1 Diabetes: a general population cohort study of children and adolescents. Diabetes Care 2006; 29: 2483-8. (Pubitemid 44912257)
3. Rostami K, Steegers EA, Wong WY, Braat DD, Steegers-Theunissen RP,. Coeliac disease and reproductive disorders: a neglected association. Eur J Obstet Gynecol Reprod Biol 2001; 96: 146-9. (Pubitemid 32522550)
4. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001; 358: 1504-8. (Pubitemid 33055702)
5. Ludvigsson JF, Olen O, Bell M, Ekbom A, Montgomery SM,. Coeliac disease and risk of sepsis. Gut 2008; 57: 1074-80.
6. WHO. Tuberculosis. Geneva: WHO, 2010.
7. Williams H,. Coeliac syndrome due to tuberculous enteritis. Med J Aust 1952; 2: 388-9.
8. Hindle W, Creamer B,. Significance of a flat small-intestinal mucosa. Br Med J 1965; 5459: 455-8.
9. Barry RE, Morris JS, Read AE,. A case of small-intestinal mucosal atrophy. Gut 1970; 11: 743-7.
10. Fung WP, Tan KK, Yu SF, Sho KM,. Malabsorption and subtotal villous atrophy secondary to pulmonary and intestinal tuberculosis. Gut 1970; 11: 212-6.
11. Williams AJ, Asquith P, Stableforth DE,. Susceptibility to tuberculosis in patients with coeliac disease. Tubercle 1988; 69: 267-74. (Pubitemid 19009803)
12. Peters U, Askling J, Gridley G, Ekbom A, Linet M,. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566-72. (Pubitemid 36835101)
13. Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM,. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax 2007; 62: 23-8. (Pubitemid 46101762)
14. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A,. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-67.
15. Ludvigsson JF, Brandt L, Montgomery SM, Granath F, Ekbom A,. Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol 2009; 9: 19.
16. Ludvigsson JF, Brandt L, Montgomery SM,. Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa. BMC Gastroenterol 2009; 9: 57.
17. Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F,. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302: 1171-8.
18. Stevens FM, Connolly CE, Murray JP, McCarthy CF,. Lung cavities in patients with coeliac disease. Digestion 1990; 46: 72-80. (Pubitemid 20342929)
19. Pais WP, Duerksen DR, Pettigrew NM, Bernstein CN,. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 2008; 67: 1082-7.
20. Linnersjo A, Hammar N, Gustavsson A, Reuterwall C,. Recent time trends in acute myocardial infarction in Stockholm, Sweden. Int J Cardiol 2000; 76: 17-21.
21. Michaelsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ 1998; 316: 1858-63. (Pubitemid 28276930)
22. Nnoaham KE, Clarke A,. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113-9. (Pubitemid 351228619)
23. Liu W, Cao WC, Zhang CY, et al. VDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study. Int J Tuberc Lung Dis 2004; 8: 428-34. (Pubitemid 38624850)
24. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D,. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66: 5314-21. (Pubitemid 29044625)
25. Krutzik SR, Hewison M, Liu PT, et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 2008; 181: 7115-20.
26. Frisullo G, Nociti V, Iorio R, et al. Increased CD4+ CD25+ Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. Hum Immunol 2009; 70: 430-5.
27. Chen X, Zhou B, Li M, et al. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 2007; 123: 50-9. (Pubitemid 46420558)
28. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
29. Voo KS, Wang YH, Santori FR, et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009; 106: 4793-8.
30. Cruz A, Fraga AG, Fountain JJ, et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 2010; 207: 1609-16.
31. Monteleone I, Sarra M, Del Vecchio Blanco G, et al. Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010; 184: 2211-8.
32. Granzotto M, dal BoS, Quaglia S, et al. Regulatory T-cell function is impaired in celiac disease. Dig Dis Sci 2009; 54: 1513-9.
33. Babu S, Bhat SQ, Kumar NP, et al. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis 2009; 200: 288-98.
34. Bethune MT, Khosla C,. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog 2008; 4: e34.
35. Dokladny K, Moseley PL, Ma TY,. Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeability. Am J Physiol Gastrointest Liver Physiol 2006; 290: G204-12.